NASDAQ:XGN
Exagen Inc. Stock News
$2.00
+0.130 (+6.95%)
At Close: May 23, 2024
Exagen to Announce Second Quarter 2022 Financial Results on August 4, 2022
04:05pm, Thursday, 21'st Jul 2022
SAN DIEGO, July 21, 2022 (GLOBE NEWSWIRE) -- Exagen Inc. (Nasdaq: XGN), a leading provider of autoimmune testing solutions, will release financial results for the quarter ended June 30, 2022, after
Exagen Inc. to Participate in the William Blair 42nd Annual Growth Stock Conference
08:05pm, Thursday, 26'th May 2022 GlobeNewswire Inc.
SAN DIEGO, May 26, 2022 (GLOBE NEWSWIRE) -- Exagen Inc. (Nasdaq: XGN), a leading provider of autoimmune testing solutions, today announced its participation in the William Blair 42nd Annual Growth
Exagen Inc. Expands Coverage with Alivio Health, Partnering to Provide More Accurate Diagnostic Testing with AVISE® CTD and AVISE® Lupus
08:05pm, Monday, 16'th May 2022 GlobeNewswire Inc.
SAN DIEGO, May 16, 2022 (GLOBE NEWSWIRE) -- Exagen Inc. (Nasdaq: XGN), a leading provider of autoimmune testing solutions, announced today that AVISE® CTD and AVISE® Lupus are a contracted cover
Exagen Inc. (XGN) Q1 2022 Earnings Call Transcript
03:30am, Thursday, 12'th May 2022 The Motley Fool
XGN earnings call for the period ending March 31, 2022.
Exagen Inc. (XGN) Reports Q1 Loss, Tops Revenue Estimates
09:55pm, Wednesday, 11'th May 2022 Zacks Investment Research
Exagen Inc. (XGN) delivered earnings and revenue surprises of -1.69% and 2.91%, respectively, for the quarter ended March 2022. Do the numbers hold clues to what lies ahead for the stock?
Exagen Inc. (XGN) CEO Ron Rocca on Q1 2022 Results - Earnings Call Transcript
08:41pm, Wednesday, 11'th May 2022
Exagen Inc. (NASDAQ:XGN ) Q1 2022 Earnings Conference Call May 11, 2022 4:30 PM ET Company Participants Ryan Douglas - Investor Relations Ron Rocca - President and Chief Executive Officer Kamal Adawi
Exagen Inc. Announces New PLA Code and Medicare Pricing for Proprietary AVISE® Lupus Test
08:06pm, Wednesday, 11'th May 2022 GlobeNewswire Inc.
SAN DIEGO, May 11, 2022 (GLOBE NEWSWIRE) -- Exagen Inc. (Nasdaq: XGN), a leading provider of autoimmune testing solutions, announced today that Medicare Administrative Contractor (MAC) Noridian ha
Exagen Inc. Reports First Quarter 2022 Results
08:05pm, Wednesday, 11'th May 2022 GlobeNewswire Inc.
Records in Ordering Healthcare Providers and Adopters, Set All-Time Record for AVISE® CTD Monthly Volume in March Records in Ordering Healthcare Providers and Adopters, Set All-Time Record for AVISE�
Exagen Inc. (XGN) Reports Q1 Loss, Tops Revenue Estimates
07:34pm, Wednesday, 11'th May 2022
Exagen Inc. (XGN) delivered earnings and revenue surprises of -1.69% and 2.91%, respectively, for the quarter ended March 2022. Do the numbers hold clues to what lies ahead for the stock?
AdaptHealth Corp. (AHCO) Reports Q1 Loss, Tops Revenue Estimates
02:45pm, Tuesday, 10'th May 2022 Zacks Investment Research
AdaptHealth Corp. (AHCO) delivered earnings and revenue surprises of -109.52% and 9.81%, respectively, for the quarter ended March 2022. Do the numbers hold clues to what lies ahead for the stock?
MacroGenics (MGNX) Reports Q1 Loss, Lags Revenue Estimates
09:15pm, Tuesday, 03'rd May 2022 Zacks Investment Research
MacroGenics (MGNX) delivered earnings and revenue surprises of -28.57% and 35.46%, respectively, for the quarter ended March 2022. Do the numbers hold clues to what lies ahead for the stock?
Exagen Announces Five-Week Campaign for Lupus Awareness Month
04:00pm, Sunday, 01'st May 2022 GlobeNewswire Inc.
SAN DIEGO, May 01, 2022 (GLOBE NEWSWIRE) -- Exagen Inc. (Nasdaq: XGN), a leading provider of autoimmune testing solutions, today announced, in recognition of Lupus Awareness Month, the launch of a
Exagen to Announce First Quarter 2022 Financial Results on May 11, 2022
08:05pm, Monday, 25'th Apr 2022 GlobeNewswire Inc.
SAN DIEGO, April 25, 2022 (GLOBE NEWSWIRE) -- Exagen Inc. (Nasdaq: XGN), a leading provider of autoimmune testing solutions, will release financial results for the quarter ended March 31, 2022, af
Exagen to Announce First Quarter 2022 Financial Results on May 11, 2022
04:05pm, Monday, 25'th Apr 2022
SAN DIEGO, April 25, 2022 (GLOBE NEWSWIRE) -- Exagen Inc. (Nasdaq: XGN), a leading provider of autoimmune testing solutions, will release financial results for the quarter ended March 31, 2022, afte
Exagen Inc. to Participate in Investor Summit Group’s Q2 Conference
08:05pm, Wednesday, 20'th Apr 2022 GlobeNewswire Inc.
SAN DIEGO, April 20, 2022 (GLOBE NEWSWIRE) -- Exagen Inc. (Nasdaq: XGN), a leading provider of autoimmune testing solutions, today announced its participation in Investor Summit Group’s Q2 Conf
